Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-06
1985-10-01
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548216, 549486, C07D49810, C07D26344, A61K 3142
Patent
active
045446628
ABSTRACT:
The invention provides novel spiro[oxazolidine-5,3'-indoline]-2,2',4-triones of formula I bearing substituted benzyl or cinnamyl on the indoline nitrogen, together with salts and non-toxic, biodegradable precursors thereof. The compounds are potent inhibitors of the enzyme aldose reductase and are useful in treating or preventing certain diabetic complications. The invention also provides pharmaceutical compositions containing, and processes for the manufacture of, the compounds of formula I and their salts and derivatives.
REFERENCES:
patent: 4200642 (1980-04-01), Schnur
patent: 4226875 (1980-10-01), Schnur
Clark-Lewis et al., J. Chem. Soc., 1965, 5551-5556.
Brittain David R.
Wood Robin
Daus Donald G.
Gibson S. A.
Imperial Chemical Industries
LandOfFree
1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1442739